August 30, 2024

SGLT2 Inhibitor and Urinary Tract Infection in Men at Risk for Voiding Dysfunction: A VigiBase Analysis

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

We investigated the risk of UTIs and complex UTIs associated with SGLT2 (sodium-glucose cotransporter-2) inhibitors in men, emphasizing older men at higher risk for voiding dysfunction.

Me gusta

Guardar

Me gusta

Guardar

Cite This Study

Qian et al. (Fri,) studied this question.

synapsesocial.com/papers/68e5a3f3b6db64358753e1ac https://doi.org/https://doi.org/10.1097/upj.0000000000000698

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Gender Differences in the Clinical Profile of Sodium-Glucose Cotransporter-2 Inhibitor-Related Urinary Tract Infections2024 · 2 citations
2SGLT2 Inhibitors and genital infections: a prospective observational study in a tertiary care hospital2025 · 1 citations
3MP69-16 ASSESSING THE RISK OF URINARY TRACT INFECTIONS ASSOCIATED WITH SGLT2 INHIBITORS IN MEN: A VIGIBASE ANALYSIS2024
4The prevalence and predictor factors of urinary tract infection in type 2 diabetes mellitus patients receiving SGLT2 inhibitors in Qatar: A retrospective cohort study2026
5Frequency of Urinary Tract Infections in Diabetic Patients Taking SGLT-2 Inhibitors2025